A Delaware judge has rejected the efforts of Intel Corp. to compel the genetic testing of two employees who allege their son’s birth defects were caused by their exposure to pollutants while working at the technology company.
Intel sought to compel “Trio Whole Exome Sequencing,” or sequencing all the genes that code proteins, of Janna and Robert Meyers. Most single-genetic mutations are located in the part of the human genome that codes for proteins, according to the National Institutes of Health.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
